KALU:NASDAQKaiser Aluminum Corporation Analysis
Data as of 2026-04-12 - not real-time
$142.67
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Kaiser Aluminum (KALU) is trading at $142.67, well above its 20‑day SMA of $122.30 and the 200‑day SMA of $100.83, yet just shy of the 50‑day SMA of $128.18, indicating a short‑term rally that may be losing steam. The RSI of 69.3 suggests the stock is approaching overbought territory, while a bullish MACD (line $3.82 above signal $0.56) confirms recent momentum but does not guarantee further upside as price nears the resistance level of $144.52. Volatility is elevated at ~50% over the past 30 days and beta of 1.65 points to heightened sensitivity to market swings, compounded by decreasing volume trends. Fundamentally, revenue is growing 21% year‑over‑year with modest gross (13%) and operating (6.4%) margins, a forward EPS of $9.12 and a forward P/E of 15.6, but free cash flow is negative and debt‑to‑equity sits at an extreme 133%, raising concerns about cash generation. The DCF‑derived fair value of $88.67 implies the stock is overvalued by roughly 12‑13%, and the dividend yield of 2.16% is supported by a 45% payout ratio that may be strained given the cash flow profile. Recent news of strong two‑day price momentum and upbeat commentary on aluminum as “the new oil” fuels short‑term enthusiasm, but sector turbulence linked to geopolitical events and the company’s high leverage temper optimism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI near 70 indicating overbought conditions
- Price approaching resistance at $144.52
- Decreasing volume despite recent rally
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth (21%) and improving forward P/E
- High leverage (debt‑to‑equity 133%) and negative free cash flow
- Valuation gap: market price > DCF fair value by ~12%
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Overvaluation relative to intrinsic value and downside potential
- Elevated sector volatility and beta
- Sustained cash flow weakness and debt burden
Key Metrics & Analysis
Financial Health
Revenue Growth21.40%
Profit Margin3.34%
P/E Ratio21.0
ROE14.34%
ROA4.66%
Debt/Equity133.25
P/B Ratio2.8
Op. Cash Flow$111.4M
Free Cash Flow$-76712496
Technical Analysis
TrendNeutral
RSI69.3
Support$105.45
Resistance$144.52
MA 20$122.30
MA 50$128.18
MA 200$100.83
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Fair Value$88.67
Target Price$124.50
Upside/Downside-12.74%
GradeOvervalued
TypeGrowth
Dividend Yield2.16%
Risk Assessment
Beta1.65
Volatility50.24%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.